Matthew E. Monaghan - 01 Apr 2022 Form 4 Insider Report for INVACARE CORP

Role: Chairman, President and CEO, Director
Signature: /s/ Matthew E. Monaghan, by Kristofer K. Spreen, his attorney-in-fact, pursuant to Power of Attorney, dated March 31, 2015, on file with the Commission
Issuer symbol: N/A
Transactions as of: 01 Apr 2022
Net transactions value: $0
Form type: 4
Filing time: 05 Apr 2022, 16:47:06 UTC
Previous filing: 14 Mar 2022
Next filing: 17 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IVC	Common Shares	Award	$0	+294,391	+28%	$0.000000	1,346,737	01 Apr 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	IVC	Employee Stock Option (Right to Buy)						400,000	01 Apr 2022	Common Shares	400,000		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted shares granted pursuant to the Invacare Corporation 2018 Equity Compensation Plan in an exempt transaction under Rule 16b-3. These shares vest in 1/3 annual increments over three years commencing on May 15, 2023.
F2	No transaction is being reported on this line. Reported on a previously filed Form 4.